Notice: This company has been marked as potentially delisted and may not be actively trading. MyMD Pharmaceuticals (MYM) News Today Add Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period TNF Pharmaceuticals to initiate MYMD-1 Phase II clinical trialsAugust 22, 2024 | finance.yahoo.comTNF Pharmaceuticals, Inc.July 25, 2024 | cnn.comTNF Pharmaceuticals (Formerly MyMD Pharmaceuticals) Begins Trading Under New Nasdaq Stock Symbol "TNFA" Effective Before Market Open TodayJuly 24, 2024 | finance.yahoo.comMyMD Pharma announces rebranding to TNF PharmaceuticalsJuly 22, 2024 | msn.comMyMD Pharmaceuticals Announces Corporate Rebranding to New Name TNF Pharmaceuticals, Inc.July 22, 2024 | finance.yahoo.comTandem Diabetes Care, Guardion Health, GT Biopharma among healthcare moversMay 21, 2024 | msn.comAsia FX weakens; yen, dollar rise on fears of Iran-Israel escalationApril 20, 2024 | msn.comJPMorgan’s India equity preview favors domestic cyclical playsApril 13, 2024 | uk.investing.comOil prices steady amid Middle East tensions, US inventory buildApril 11, 2024 | msn.comDelveInsight Business Research, LLP: Giant-Cell Arteritis Market to Showcase Positive Growth at a CAGR of 9.3% by 2034 | DelveInsightApril 8, 2024 | finanznachrichten.deSwiss National Bank's Jordan against issuing retail cenbank digital currencyApril 8, 2024 | msn.comEaster food spending lifts UK retail sales by most since AugustApril 8, 2024 | uk.investing.comGiant-Cell Arteritis Market to Showcase Positive Growth at a CAGR of 9.3% by 2034 | DelveInsightApril 8, 2024 | finance.yahoo.comFashion retailer H&M's Q1 operating profit rises more than expectedMarch 27, 2024 | uk.investing.comMost rescue efforts at Russian gold mine have been suspended due to risk of another collapse -TASSMarch 27, 2024 | uk.investing.comSarcopenia Market Expected to Grow with Advancements in Treatment and Diagnosis by 2032March 18, 2024 | finance.yahoo.comMyMD Pharmaceuticals Announces Reverse Stock Split to Maintain Nasdaq ListingFebruary 13, 2024 | finance.yahoo.comMyMD Pharmaceuticals Releases Positive Clinical Trial Results For Sarcopenia Treatment DrugDecember 28, 2023 | benzinga.comMyMD Pharmaceuticals Plans FDA-Cleared Phase 2 Clinical Trial of MYMD-1 in Rheumatoid ArthritisDecember 6, 2023 | finance.yahoo.comMyMD Pharmaceuticals to Present Updated Statistically Significant Phase 2 Data for MYMD-1, Potential TNF-α Market Disrupter, at BioFuture 2023October 4, 2023 | finance.yahoo.comMyMD Pharmaceuticals And 2 Other Penny Stocks Insiders Are Aggressively BuyingAugust 25, 2023 | benzinga.comBaltimore's MIRA Pharmaceuticals raises $8.9 million from IPOAugust 9, 2023 | bizjournals.comWhy Is MyMD Pharmaceuticals Stock Gaining Today?July 31, 2023 | msn.comWhy Caribou Biosciences Shares Are Trading Higher By Around 58%? Here Are Other Stocks Moving In Thursday's SessionJuly 6, 2023 | msn.comUnusual Call Option Trade in MyMD Pharmaceuticals (MYMD) Worth $15.98KMay 1, 2023 | msn.comMyMD stock dips amid dosing updates on aging therapy MYMD-1April 12, 2023 | msn.comMyMD Joins LOT Network in Effort to Protect Company and Shareholders from Patent TrollsMarch 8, 2023 | finance.yahoo.comMyMD says DEA found that its cannabinoid Supera-CBD is not a controlled substanceMarch 2, 2023 | msn.comDEA Concludes MyMD's Supera-CBD Is Not A Controlled Substance Or Listed ChemicalMarch 2, 2023 | msn.comMyMD Pharmaceuticals to raise $15M from current investorsFebruary 21, 2023 | msn.comGlenmark Pharmaceuticals launches Bumetanide Injection USP, 1 mg/4 mL (0.25 mg/mL) Single-Dose Vials and 2.5 mg/10 mL (0.25 mg/mL) Multi-Dose VialsJanuary 12, 2023 | markets.businessinsider.comMyMD Pharmaceuticals® to Present Data on Oral TNF-a Inhibitor MYMD-1® at the British Society for Immunology (BSI) Congress 2022December 6, 2022 | finance.yahoo.comMyMD Pharmaceuticals® Announces Upcoming Presentation of Late-Breaking Data for MYMD-1® at the 2022 British Society for Immunology (BSI) CongressNovember 17, 2022 | finance.yahoo.comMultiple insiders bought MyMD Pharmaceuticals, Inc. (NASDAQ:MYMD) stock earlier this year, a positive sign for shareholdersOctober 30, 2022 | finance.yahoo.comMyMD Pharma: Phase 2 Trial Of MYMD-1 Progresses Into Next Dosing CohortSeptember 20, 2022 | markets.businessinsider.comMyMD Pharmaceuticals Inc.August 18, 2022 | barrons.comData Showing MyMD Pharmaceuticals’ MYMD-1® May Extend Life and Improve Health Published in the Journal of Gerontology: Biological SciencesAugust 3, 2022 | yahoo.comMyMD Pharmaceuticals Inc Ordinary Shares - Stock Quote MYMDJune 14, 2022 | morningstar.comWe're Keeping An Eye On MyMD Pharmaceuticals' (NASDAQ:MYMD) Cash Burn RateFebruary 20, 2022 | nz.finance.yahoo.comMyMD Pharmaceuticals Announces Positive Clinical Data in Advance of Upcoming Phase 2 Trial of MYMD-1 for Extending Healthy LifespanFebruary 8, 2022 | finance.yahoo.comMyMD : Oravax Medical Signs Deal For Initial Pre-Purchase Of 10 Mln Doses Of Oral COVID-19 VaccineDecember 29, 2021 | nasdaq.comMyMD Pharmaceuticals Investment Company Oravax Medical Signs Cooperation and Purchase Agreement for Initial Pre-Purchase of 10 Million Doses of Oral COVID-19 Vaccine to be ...December 29, 2021 | businesswire.comProspective patient population of approximately 660 million throughout the Association of Southeast Asian NationsDecember 29, 2021 | morningstar.comPremas Biotech and Oravax Medical to Test Their Triple Antigen Oral Vaccine Candidate Against Omicron Variant of ConcernDecember 1, 2021 | finance.yahoo.comMyMD Pharmaceuticals Investment Company Oravax Medical and Genomma Lab Announce Joint Venture to Develop and Commercialize Oral COVID-19 Vaccine in Mexico and Drive Business ...November 18, 2021 | businesswire.comA First-of-its-Kind Drug Candidate Targeting the Root Causes of Aging Could Soon Dominate Estimated $600 Billion Aging MarketOctober 20, 2021 | news.yahoo.comBenzinga Announces The 8 'Rising Star' Companies Being Featured On Its Next 'All Access' ShowOctober 6, 2021 | msn.comMyMD Pharmaceuticals to Detail its Two Upcoming Phase 2 Trials at the Benzinga Rising Stars: Catalytic Small Cap Growth Conference on October 7October 6, 2021 | benzinga.comMyMD Pharma Shares Up After Lead Compound Shown to Suppress a Major Cause of Death in Covid-19August 5, 2021 | marketwatch.comMyMD Pharmaceuticals’ Lead Compound MYMD-1 Shown to Suppress a Major Cause of Death in COVID-19 in Human Cell StudyAugust 5, 2021 | finance.yahoo.com Get MyMD Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for MYM and its competitors with MarketBeat's FREE daily newsletter. Email Address The Final Frontier (Ad)And a lot of powerful investors would rather this exposé never saw the light of day. I suspect they’ll attempt to discredit it, tar and feather it, and convince you not to watch it. That’s because it tells the shocking truth about the current AI mania… and why investors in big tech companies like Nvidia, Meta, Alphabet, and Microsoft could be in for a whole world of pain. Here’s the full story for you. MYM Media Mentions By Week MYM Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MYM News Sentiment▼0.000.42▲Average News Sentiment MYM News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MYM Articles This Week▼00▲MYM Articles Average Week Get MyMD Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for MYM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:MYM) was last updated on 11/4/2024 by MarketBeat.com Staff From Our Partners2 sentences that change everything you THOUGHT you knew about tradingIf you're like most people, on Friday morning you'll probably follow your set routine: Wake up... eat breakfas...Investing Daily | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | SponsoredA Totally New ‘Income Coin’Buckle up… Because this might shatter everything you thought you knew about "income trading." In fact, i...Crypto 101 Media | SponsoredThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MyMD Pharmaceuticals Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share MyMD Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MYM Stock Alerts